Artículos de revistas sobre el tema "C3-convertase of alternative complement pathway"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "C3-convertase of alternative complement pathway".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Hourcade, Dennis E., Lynne M. Mitchell y M. Edward Medof. "Decay acceleration of the complement alternative pathway C3 convertase". Immunopharmacology 42, n.º 1-3 (mayo de 1999): 167–73. http://dx.doi.org/10.1016/s0162-3109(99)00005-3.
Texto completoRoumenina, Lubka T., Mathieu Jablonski, Christophe Hue, Jacques Blouin, Jordan D. Dimitrov, Marie-Agnes Dragon-Durey, Mathieu Cayla et al. "Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome". Blood 114, n.º 13 (24 de septiembre de 2009): 2837–45. http://dx.doi.org/10.1182/blood-2009-01-197640.
Texto completoMullick, Jayati, John Bernet, Yogesh Panse, Sharanabasava Hallihosur, Akhilesh K. Singh y Arvind Sahu. "Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein". Journal of Virology 79, n.º 19 (1 de octubre de 2005): 12382–93. http://dx.doi.org/10.1128/jvi.79.19.12382-12393.2005.
Texto completoSchwendinger, M. G., M. Spruth, J. Schoch, M. P. Dierich y W. M. Prodinger. "A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells." Journal of Immunology 158, n.º 11 (1 de junio de 1997): 5455–63. http://dx.doi.org/10.4049/jimmunol.158.11.5455.
Texto completoChauvet, Sophie, Romain Berthaud, Magali Devriese, Morgane Mignotet, Paula Vieira Martins, Tania Robe-Rybkine, Maria A. Miteva et al. "Anti-Factor B Antibodies and Acute Postinfectious GN in Children". Journal of the American Society of Nephrology 31, n.º 4 (7 de febrero de 2020): 829–40. http://dx.doi.org/10.1681/asn.2019080851.
Texto completoWeiler, J. M., R. E. Edens y G. J. Gleich. "Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway." Journal of Immunology 149, n.º 2 (15 de julio de 1992): 643–48. http://dx.doi.org/10.4049/jimmunol.149.2.643.
Texto completoIrmscher, Sarah, Nadia Döring, Luke D. Halder, Emeraldo A. H. Jo, Isabell Kopka, Christine Dunker, Ilse D. Jacobsen et al. "Kallikrein Cleaves C3 and Activates Complement". Journal of Innate Immunity 10, n.º 2 (14 de diciembre de 2017): 94–105. http://dx.doi.org/10.1159/000484257.
Texto completoPangburn, M. K. y H. J. Müller-Eberhard. "The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase". Biochemical Journal 235, n.º 3 (1 de mayo de 1986): 723–30. http://dx.doi.org/10.1042/bj2350723.
Texto completoSahu, Arvind, Stuart N. Isaacs, Athena M. Soulika y John D. Lambris. "Interaction of Vaccinia Virus Complement Control Protein with Human Complement Proteins: Factor I-Mediated Degradation of C3b to iC3b1 Inactivates the Alternative Complement Pathway". Journal of Immunology 160, n.º 11 (1 de junio de 1998): 5596–604. http://dx.doi.org/10.4049/jimmunol.160.11.5596.
Texto completoJiang, Haixiang, Eric Wagner, Huamei Zhang y Michael M. Frank. "Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway". Journal of Experimental Medicine 194, n.º 11 (3 de diciembre de 2001): 1609–16. http://dx.doi.org/10.1084/jem.194.11.1609.
Texto completoJongerius, Ilse, Jörg Köhl, Manoj K. Pandey, Maartje Ruyken, Kok P. M. van Kessel, Jos A. G. van Strijp y Suzan H. M. Rooijakkers. "Staphylococcal complement evasion by various convertase-blocking molecules". Journal of Experimental Medicine 204, n.º 10 (24 de septiembre de 2007): 2461–71. http://dx.doi.org/10.1084/jem.20070818.
Texto completoAgostoni, A., M. Cicardi, M. Gardinali y L. Bergamaschini. "The Complement System". International Journal of Immunopathology and Pharmacology 5, n.º 2 (mayo de 1992): 123–30. http://dx.doi.org/10.1177/039463209200500207.
Texto completoMichelfelder, Stefan, Friedericke Fischer, Astrid Wäldin, Kim V. Hörle, Martin Pohl, Juliana Parsons, Ralf Reski et al. "The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential". Journal of the American Society of Nephrology 29, n.º 4 (15 de enero de 2018): 1141–53. http://dx.doi.org/10.1681/asn.2017070738.
Texto completoInal, Jameel Malhador, Andreas Laich y Sylvie Miot. "Complement C2 bypass mechanism involving the C3-convertase C4bBb (53.16)". Journal of Immunology 178, n.º 1_Supplement (1 de abril de 2007): S106. http://dx.doi.org/10.4049/jimmunol.178.supp.53.16.
Texto completoWilcox, LA, JL Ezzell, NJ Bernshaw y CJ Parker. "Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum". Blood 78, n.º 3 (1 de agosto de 1991): 820–29. http://dx.doi.org/10.1182/blood.v78.3.820.bloodjournal783820.
Texto completoNolasco, Jennifer, Leticia Nolasco, Qi Da, Sonya Cirlos, Zaverio Ruggeri, Joel Moake y Miguel Cruz. "Complement Component C3 Binds to the A3 Domain of von Willebrand Factor". TH Open 02, n.º 03 (julio de 2018): e338-e345. http://dx.doi.org/10.1055/s-0038-1672189.
Texto completoKinoshita, T., A. W. Dodds, S. K. A. Law y K. Inoue. "The low C5 convertase activity of the C4A6 allotype of human complement component C4". Biochemical Journal 261, n.º 3 (1 de agosto de 1989): 743–48. http://dx.doi.org/10.1042/bj2610743.
Texto completoHindmarsh, Elizabeth J. y Rory M. Marks. "Complement Activation Occurs on Subendothelial Extracellular Matrix In Vitro and Is Initiated by Retraction or Removal of Overlying Endothelial Cells". Journal of Immunology 160, n.º 12 (15 de junio de 1998): 6128–36. http://dx.doi.org/10.4049/jimmunol.160.12.6128.
Texto completoKinoshita, T., Y. Takata, H. Kozono, J. Takeda, K. S. Hong y K. Inoue. "C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme." Journal of Immunology 141, n.º 11 (1 de diciembre de 1988): 3895–901. http://dx.doi.org/10.4049/jimmunol.141.11.3895.
Texto completoIatropoulos, Paraskevas, Erica Daina, Manuela Curreri, Rossella Piras, Elisabetta Valoti, Caterina Mele, Elena Bresin et al. "Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN". Journal of the American Society of Nephrology 29, n.º 1 (13 de octubre de 2017): 283–94. http://dx.doi.org/10.1681/asn.2017030258.
Texto completoJELEZAROVA, Emiliana, Anna VOGT y Hans U. LUTZ. "Interaction of C3b2–IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification". Biochemical Journal 349, n.º 1 (26 de junio de 2000): 217–23. http://dx.doi.org/10.1042/bj3490217.
Texto completoMold, C., B. M. Bradt, G. R. Nemerow y N. R. Cooper. "Epstein-Barr virus regulates activation and processing of the third component of complement." Journal of Experimental Medicine 168, n.º 3 (1 de septiembre de 1988): 949–69. http://dx.doi.org/10.1084/jem.168.3.949.
Texto completoWilcox, LA, JL Ezzell, NJ Bernshaw y CJ Parker. "Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum". Blood 78, n.º 3 (1 de agosto de 1991): 820–29. http://dx.doi.org/10.1182/blood.v78.3.820.820.
Texto completoMoulton, Elizabeth A., Paula Bertram, Nanhai Chen, R. Mark L. Buller y John P. Atkinson. "Ectromelia Virus Inhibitor of Complement Enzymes Protects Intracellular Mature Virus and Infected Cells from Mouse Complement". Journal of Virology 84, n.º 18 (7 de julio de 2010): 9128–39. http://dx.doi.org/10.1128/jvi.02677-09.
Texto completoKim, Y. U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner y V. M. Holers. "Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein." Journal of Experimental Medicine 181, n.º 1 (1 de enero de 1995): 151–59. http://dx.doi.org/10.1084/jem.181.1.151.
Texto completoMatsushita, M. y H. Okada. "Alternative complement pathway activation by C4b deposited during classical pathway activation." Journal of Immunology 136, n.º 8 (15 de abril de 1986): 2994–98. http://dx.doi.org/10.4049/jimmunol.136.8.2994.
Texto completoMurray, Hannah, Beiying Qiu, Sze Yuan Ho y Xiaomeng Wang. "Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway". International Journal of Molecular Sciences 22, n.º 17 (3 de septiembre de 2021): 9580. http://dx.doi.org/10.3390/ijms22179580.
Texto completoAlcorlo, M., A. Tortajada, S. Rodriguez de Cordoba y O. Llorca. "Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin". Proceedings of the National Academy of Sciences 110, n.º 33 (30 de julio de 2013): 13504–9. http://dx.doi.org/10.1073/pnas.1309618110.
Texto completoHolguin, M. H., C. B. Martin, N. J. Bernshaw y C. J. Parker. "Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor." Journal of Immunology 148, n.º 2 (15 de enero de 1992): 498–502. http://dx.doi.org/10.4049/jimmunol.148.2.498.
Texto completoManderson, Anthony P., Matthew C. Pickering, Marina Botto, Mark J. Walport y Christopher R. Parish. "Continual Low-Level Activation of the Classical Complement Pathway". Journal of Experimental Medicine 194, n.º 6 (10 de septiembre de 2001): 747–56. http://dx.doi.org/10.1084/jem.194.6.747.
Texto completoMeri, S., V. Koistinen, A. Miettinen, T. Törnroth y I. J. Seppälä. "Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis." Journal of Experimental Medicine 175, n.º 4 (1 de abril de 1992): 939–50. http://dx.doi.org/10.1084/jem.175.4.939.
Texto completoPedersen, Henrik, Rasmus K. Jensen, Annette G. Hansen, Trine A. F. Gadeberg, Steffen Thiel, Nick S. Laursen y Gregers R. Andersen. "A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system". Journal of Biological Chemistry 295, n.º 26 (6 de mayo de 2020): 8746–58. http://dx.doi.org/10.1074/jbc.ra119.012339.
Texto completoRisitano, Antonio M., Patrizia Ricci, Caterina Pascariello, Maddalena Raia, Christoph Q. Schmidt, Yingxue Li, Edimara S. Reis et al. "Novel Complement Modulators for Paroxysmal Nocturnal Hemoglobinuria: Peptide and Protein Inhibitors of C3 Convertase Prevent Both Surface C3 Deposition and Subsequent Hemolysis of Affected Erythrocytes in Vitro". Blood 120, n.º 21 (16 de noviembre de 2012): 370. http://dx.doi.org/10.1182/blood.v120.21.370.370.
Texto completoHiramatsu, M., J. E. Balow y G. C. Tsokos. "Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis." Journal of Immunology 136, n.º 12 (15 de junio de 1986): 4451–55. http://dx.doi.org/10.4049/jimmunol.136.12.4451.
Texto completoSahu, A., B. K. Kay y J. D. Lambris. "Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library." Journal of Immunology 157, n.º 2 (15 de julio de 1996): 884–91. http://dx.doi.org/10.4049/jimmunol.157.2.884.
Texto completoFremeaux-Bacchi, Veronique y Christoph Licht. "Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis". Thrombosis and Haemostasis 101, n.º 02 (2009): 271–78. http://dx.doi.org/10.1160/th08-09-0575.
Texto completoLindorfer, Margaret A., Andrew W. Pawluczkowycz, Elizabeth M. Peek, Kimberly Hickman, Ronald P. Taylor y Charles J. Parker. "A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement". Blood 115, n.º 11 (18 de marzo de 2010): 2283–91. http://dx.doi.org/10.1182/blood-2009-09-244285.
Texto completoCheung, A. K., C. J. Parker, J. Janatova y E. Brynda. "Modulation of complement activation on hemodialysis membranes by immobilized heparin." Journal of the American Society of Nephrology 2, n.º 8 (febrero de 1992): 1328–37. http://dx.doi.org/10.1681/asn.v281328.
Texto completoFigueroa, J. E. y P. Densen. "Infectious diseases associated with complement deficiencies." Clinical Microbiology Reviews 4, n.º 3 (julio de 1991): 359–95. http://dx.doi.org/10.1128/cmr.4.3.359.
Texto completoPangburn, M. K. y N. Rawal. "Structure and function of complement C5 convertase enzymes". Biochemical Society Transactions 30, n.º 6 (1 de noviembre de 2002): 1006–10. http://dx.doi.org/10.1042/bst0301006.
Texto completoTaylor, Ronald P., Margaret A. Lindorfer, Andrew W. Pawluczkowycz y Charles J. Parker. "A Novel Approach to Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH): Both Hemolysis and C3 Deposition Are Blocked by a Monoclonal Antibody (mAb) Specific for the Alternative Pathway of Complement (APC) C3/C5 Convertase." Blood 114, n.º 22 (20 de noviembre de 2009): 157. http://dx.doi.org/10.1182/blood.v114.22.157.157.
Texto completoRawal, Nenoo y Michael K. Pangburn. "C5 Convertase of the Alternative Pathway of Complement". Journal of Biological Chemistry 273, n.º 27 (3 de julio de 1998): 16828–35. http://dx.doi.org/10.1074/jbc.273.27.16828.
Texto completoIwata, K., T. Seya, H. Ariga y S. Nagasawa. "Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein." Journal of Immunology 152, n.º 7 (1 de abril de 1994): 3436–44. http://dx.doi.org/10.4049/jimmunol.152.7.3436.
Texto completoTu, Anh-Hue T., Robert L. Fulgham, Mark A. McCrory, David E. Briles y Alexander J. Szalai. "Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae". Infection and Immunity 67, n.º 9 (1 de septiembre de 1999): 4720–24. http://dx.doi.org/10.1128/iai.67.9.4720-4724.1999.
Texto completoISAAC, Lourdes, Dikran AIVAZIAN, Aiko TANIGUCHI-SIDLE, O. Roger EBANKS, S. Chuck FARAH, Marlene P. C. FLORIDO, K. Michael PANGBURN y E. David ISENMAN. "Native conformations of human complement components C3 and C4 show different dependencies on thioester formation". Biochemical Journal 329, n.º 3 (1 de febrero de 1998): 705–12. http://dx.doi.org/10.1042/bj3290705.
Texto completoKimura, Yuko, Takashi Miwa, Lin Zhou y Wen-Chao Song. "Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement". Blood 111, n.º 2 (15 de enero de 2008): 732–40. http://dx.doi.org/10.1182/blood-2007-05-089821.
Texto completoKoistinen, V. "Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b". Biochemical Journal 280, n.º 1 (15 de noviembre de 1991): 255–59. http://dx.doi.org/10.1042/bj2800255.
Texto completoRooijakkers, Suzan H. M., Jin Wu, Maartje Ruyken, Robert van Domselaar, Karel L. Planken, Apostolia Tzekou, Daniel Ricklin et al. "Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor". Nature Immunology 10, n.º 7 (7 de junio de 2009): 721–27. http://dx.doi.org/10.1038/ni.1756.
Texto completoJelezarova, Emiliana y Hans U. Lutz. "IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase". Molecular Immunology 42, n.º 11 (julio de 2005): 1393–403. http://dx.doi.org/10.1016/j.molimm.2004.12.014.
Texto completoRicklin, Daniel. "Manipulating the mediator: Modulation of the alternative complement pathway C3 convertase in health, disease and therapy". Immunobiology 217, n.º 11 (noviembre de 2012): 1057–66. http://dx.doi.org/10.1016/j.imbio.2012.07.016.
Texto completo